Dexcom | DXCM - Capital Social Ordinario

Precio De Mercado
61.57
Cambio Diario
-1.13 -1.80%
Mensual
-7.88%
Anual
-14.08%
Q2 Expectativa
60.25




Capital Social Ordinario Cambio Fecha
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.75M 736K 2025-12
AtriCure USD 49.7M 10K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Globus Medical USD 135.06M 449K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
J&J USD 2.41B 1.74M 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.29M 72K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
West Pharmaceutical Services USD 70.9M 1.1M 2026-03
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12